| ||
| Oncology Article | Carcinoma, Non-Small-Cell Lung Survival benefit with erlotinib maintenance therapy in patients with advanced non-small-cell lung cancer (NSCLC) according to response to first-line ... www.mdlinx.com/oncology/.../carcinoma-non-small-cell-lung |
Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.
Remove this alert.
Create another alert.
Manage your alerts.
No comments:
Post a Comment